128 related articles for article (PubMed ID: 31462952)
21. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
[TBL] [Abstract][Full Text] [Related]
22. Gallbladder opacification on gadoxetate disodium-enhanced CT scan.
Karam AR; Scortegagna E; Chen BY; Dupuis CS; Coughlin DD
Emerg Radiol; 2017 Apr; 24(2):139-142. PubMed ID: 27807654
[TBL] [Abstract][Full Text] [Related]
23. Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma.
Schalkx HJ; van Stralen M; Coenegrachts K; van den Bosch MA; van Kessel CS; van Hillegersberg R; van Erpecum KJ; Verkooijen HM; Pluim JP; Veldhuis WB; van Leeuwen MS
Eur Radiol; 2014 Sep; 24(9):2146-56. PubMed ID: 24996795
[TBL] [Abstract][Full Text] [Related]
24. Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver.
Huh J; Kim SY; Yeh BM; Lee SS; Kim KW; Wu EH; Wang ZJ; Zhao LQ; Chang WC
Korean J Radiol; 2015; 16(6):1207-15. PubMed ID: 26576109
[TBL] [Abstract][Full Text] [Related]
25. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR
Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
[TBL] [Abstract][Full Text] [Related]
26. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
Pietryga JA; Burke LM; Marin D; Jaffe TA; Bashir MR
Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864
[TBL] [Abstract][Full Text] [Related]
27. Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact.
Davenport MS; Bashir MR; Pietryga JA; Weber JT; Khalatbari S; Hussain HK
AJR Am J Roentgenol; 2014 Oct; 203(4):796-802. PubMed ID: 25055154
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the gallbladder and cystic duct patency with gadoxetate disodium enhanced MR cholangiography: prospective comparison of patients with normal gallbladder function and acute cholecystitis.
Yacoub JH; Yousuf A; Agrawal G; Thomas S; Appelbaum DE; Oto A
Acta Radiol; 2015 Jul; 56(7):782-9. PubMed ID: 25009279
[TBL] [Abstract][Full Text] [Related]
29. Fully automatic quantification of transient severe respiratory motion artifact of gadoxetate disodium-enhanced MRI during arterial phase.
Jang J; Chung YE; Kim S; Hwang D
Med Phys; 2022 Nov; 49(11):7247-7261. PubMed ID: 35754384
[TBL] [Abstract][Full Text] [Related]
30. Gadoxetate Disodium versus Gadoterate Meglumine: Quantitative Respiratory and Hemodynamic Metrics by Using Compressed-Sensing MRI.
Glessgen CG; Moor M; Stieltjes B; Winkel DJ; Block TK; Merkle EM; Heye TJ; Boll DT
Radiology; 2019 Nov; 293(2):317-326. PubMed ID: 31549944
[TBL] [Abstract][Full Text] [Related]
31. CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?
Gruber L; Rainer V; Plaikner M; Kremser C; Jaschke W; Henninger B
Eur Radiol; 2018 May; 28(5):2013-2021. PubMed ID: 29264636
[TBL] [Abstract][Full Text] [Related]
32. Gadoxetate disodium-enhanced MRI: Assessment of arterial phase artifacts and hepatobiliary uptake in a large series.
Vietti Violi N; Argiriadi P; Rosen A; Cherny M; Weiss A; Hernandez-Meza G; Babb JS; Kihira S; Lewis S; Taouli B
Eur J Radiol; 2020 Nov; 132():109313. PubMed ID: 33053495
[TBL] [Abstract][Full Text] [Related]
33. Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
Stocker D; Hectors S; Bane O; Vietti-Violi N; Said D; Kennedy P; Cuevas J; Cunha GM; Sirlin CB; Fowler KJ; Lewis S; Taouli B
Eur Radiol; 2021 Dec; 31(12):9306-9315. PubMed ID: 34043055
[TBL] [Abstract][Full Text] [Related]
34. Computed Tomography Cholangiography Using the Magnetic Resonance Contrast Agent Gadoxetate Disodium: A Phantom Study.
Dilger SKN; Nelson N; Venkatesh SK; Ehman EC; Fidler JL; Fletcher JG; McCollough CH; Yu L
Invest Radiol; 2019 Sep; 54(9):572-579. PubMed ID: 31261292
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols.
Ringe KI; von Falck C; Raatschen HJ; Wacker F; Hinrichs J
PLoS One; 2018; 13(7):e0200887. PubMed ID: 30024930
[TBL] [Abstract][Full Text] [Related]
36. The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging.
Goetschi S; Froehlich JM; Chuck NC; Curcio R; Runge VM; Andreisek G; Nanz D; Boss A
Invest Radiol; 2014 Sep; 49(9):608-19. PubMed ID: 24710201
[TBL] [Abstract][Full Text] [Related]
37. Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients.
Endrikat J; Kim SY; Sakaguchi T; Dohanish S; Breuer J
Acta Radiol; 2016 Nov; 57(11):1326-1333. PubMed ID: 26048848
[TBL] [Abstract][Full Text] [Related]
38. Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study.
Lauenstein T; Ramirez-Garrido F; Kim YH; Rha SE; Ricke J; Phongkitkarun S; Boettcher J; Gupta RT; Korpraphong P; Tanomkiat W; Furtner J; Liu PS; Henry M; Endrikat J
Invest Radiol; 2015 Jun; 50(6):416-22. PubMed ID: 25756684
[TBL] [Abstract][Full Text] [Related]
39. cDNA Microarray Analysis and Influx Transporter OATP1B1 in Liver Cells After Exposure to Gadoxetate Disodium, a Gadolinium-based Contrast Agent in MRI Liver Imaging.
Lu CC; Chen WK; Chiang JH; Tsai YF; Juan YN; Lin PC; Tyan YS; Yang JS
In Vivo; 2018; 32(3):677-684. PubMed ID: 29695578
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]